Results 21 to 30 of about 18,492 (191)

Exploration and verification of COVID-19-related hub genes in liver physiological and pathological regeneration

Frontiers in Bioengineering and Biotechnology, 2023
Objectives An acute injury is often accompanied by tissue regeneration. In this process, epithelial cells show a tendency of cell proliferation under the induction of injury stress, inflammatory factors, and other factors, accompanied by a temporary ...
Jihang Shi, Jihang Shi, Jihang Shi, Guangya Li, Guangya Li, Xiandun Yuan, Yafei Wang, Yafei Wang, Yafei Wang, Ming Gong, Ming Gong, Ming Gong, Chonghui Li, Chonghui Li, Xinlan Ge, Xinlan Ge, Shichun Lu, Shichun Lu   +17 more
doaj   +1 more source

CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies

Journal of Experimental & Clinical Cancer Research, 2022
Cell division cycle 20 homologue (CDC20) is a well-known regulator of cell cycle, as it controls the correct segregation of chromosomes during mitosis. Many studies have focused on the biological role of CDC20 in cancer development, as alterations of its
Samantha Bruno, Andrea Ghelli Luserna di Rorà, Roberta Napolitano, Simona Soverini, Giovanni Martinelli, Giorgia Simonetti   +5 more
doaj   +1 more source

Regulated degradation of the APC coactivator Cdc20

Cell Division, 2010
Background Cdc20 is a highly conserved activator of the anaphase-promoting complex (APC), promoting cell-cycle-regulated ubiquitination and proteolysis of a number of critical cell-cycle-regulatory targets including securin and mitotic cyclins. APC-Cdc20
Robbins Jonathan A, Cross Frederick R
doaj   +1 more source

p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma

Experimental Hematology & Oncology, 2023
Background Cell cycle dysregulation characterized by cyclin D1 overexpression is common in mantle cell lymphoma (MCL), while mitotic disorder was less studied. Cell division cycle 20 homologue (CDC20), an essential mitotic regulator, was highly expressed
Yingtong Chen, Ping Yang, Jing Wang, Shuang Gao, Shiyu Xiao, Weilong Zhang, Mingxia Zhu, Yanfang Wang, Xiaoyan Ke, Hongmei Jing   +9 more
doaj   +1 more source

Modeling Dual Pathways for the Metazoan Spindle Assembly Checkpoint [PDF]

, 2006
Using computational modelling, we investigate mechanisms of signal transduction focusing on the spindle assembly checkpoint where a single unattached kinetochore is able to signal to prevent cell cycle progression.
Acquaviva, Castro, Clute, De Antoni, DeAntoni, Heinrich, Howell, Kraft, Lang, Luo, M. Howard, Mapelli, McEwen, Musacchio, Nasmyth, Nickell, Northrup, Pan, R. P. Sear, Rieder, Rieder, Rieder, Shah, Sironi, Sudakin, Tang, Tang, Vink, Wojcieszyn, Wollman   +29 more
core   +3 more sources

TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching. [PDF]

, 2015
The AAA+ family ATPase TRIP13 is a key regulator of meiotic recombination and the spindle assembly checkpoint, acting on signaling proteins of the conserved HORMA domain family.
Corbett, Kevin D, Moeller, Arne, Rosenberg, Scott C, Speir, Jeffrey A, Su, Tiffany Y, Ye, Qiaozhen   +5 more
core   +2 more sources

M2I-1 disrupts the in vivo interaction between CDC20 and MAD2 and increases the sensitivities of cancer cell lines to anti-mitotic drugs via MCL-1s [PDF]

, 2019
Background Drugs such as taxanes, epothilones, and vinca alkaloids are widely used in the treatment of breast, ovarian, and lung cancers but come with major side effects such as neuropathy and loss of neutrophils and as single agents have a lack of ...
Dang, Nanmao, Gao, Fei, Huang, Dong, Huang, Jun-Yong, Jowsey, Paul, Li, Jianquan, Lightowlers, Robert N., Martinez-Lopez, Nuria   +7 more
core   +1 more source

Targeting cell cycle proteins in breast cancer cells with siRNA by using lipid-substituted polyethylenimines

Frontiers in Bioengineering and Biotechnology, 2015
The cell cycle proteins are key regulators of cell cycle progression whose de-regulation is one of the causes of breast cancer. RNA interference (RNAi) is an endogenous mechanism to regulate gene expression and it could serve as the basis of regulating ...
Manoj eParmar, Hamid M. Aliabadi, Parvin eMahdipoor, Cezary eKucharski, Robert eMaranchuk, Judith C Hugh, Hasan eUludag   +6 more
doaj   +1 more source

Therapeutic target discovery using Boolean network attractors: avoiding pathological phenotypes [PDF]

, 2014
Target identification, one of the steps of drug discovery, aims at identifying biomolecules whose function should be therapeutically altered in order to cure the considered pathology.
Boissel, Jean-Pierre, Poret, Arnaud
core   +4 more sources

CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression [PDF]

Zhongguo aizheng zazhi
Background and purpose: Esophageal carcinoma (ESCA) is one of the malignant tumors with high mortality rate, and the underlying mechanism of its development is largely unknown.
GUAN Ruirui, HAO Qian, ZHANG Yaqi, SUN Qinggang, CHEN Yitian, LI Xiumin, ZHOU Xiang, HAN Tao
doaj   +1 more source